Summary: Since rat organic cation transporter 1 (Oct1, Slc22a1) is expressed mainly in the liver and mediates drug transport, its activity may determine the hepatic handling of cationic drugs. Here, we studied the regulation mechanism of the expression of rat Oct1, focusing on the nuclear receptors. Various nuclear receptors are considered to regulate expressions of many genes for membrane transporters and enzymes that are involved in the drug absorption and disposition. Previously, we demonstrated that some ligands of nuclear receptors affected the transcriptional regulation of rat Oct1 when examined in the primary cultured rat hepatocytes. In the present study, dexamethasone, a ligand of glucocorticoid receptor, down-regulated the expression of rat Oct1. In addition, the transport activity of rat Oct1, evaluated by the uptake of substrates of rat Oct1, was decreased by treatment of dexamethasone in comparison with untreated rat hepatocytes, showing a good agreement with the change in mRNA level. In conclusion, these observations suggested that the expression of rat Oct1 gene and the apparent organic cation uptake activity of rat hepatocytes are down-regulated by dexamethasone presumably via a glucocorticoid receptor.
Introduction
The cellular uptake and metabolism of endobiotic and xenobiotic substances are essential function of the liver. 1) Many pharmacologically active agents are cationic and are taken up by the liver prior to biotransformation and/or excretion. Membrane transport of organic cations, which include many clinically used drugs and endogenous compounds, is mediated by the family of organic cation transporters. There are three members of the organic cation transporter (OCT) family. In humans, OCT1 and OCT2 are exclusively expressed in the liver and kidney, respectively, whereas OCT3 is expressed in multiple tissues, including skeletal muscle, liver, placenta, kidney and brain. 2) In rodents, Oct1 is mainly expressed in the liver, and the less expression of Oct1 was also observed in kidney and small intestine.
3) Oct2 has a substrate specificity similar to that of Oct1, but is predominantly expressed in the kidney, as is the case in humans. 4, 5) In addition, it was reported that Oct1 gene-knockout mice showed reduced hepatic uptake and direct intestinal excretion of Oct1 substrates, indicating that this transporter plays an essential role in the disposition of organic cations in the liver and intestine. 6, 7) Despite its expression in the kidney, loss of Oct1 from the kidney is unlikely to affect the renal elimination of organic cations, while studies of Oct1 and Oct2 double knockout mice showed the decrease of renal secretion of organic cations. 8) Accordingly, Oct1 may be less effective than Oct2 in kidney.
Although OCTs are deeply associated with the pharmacokinetic properties of drugs, information about the involvement of OCTs in drug-induced adverse effects is limited. It has been reported that nephrotoxicity induced by platinum-based drugs is affected by the transport activity of OCTs, since the concentration of platinum agents in kidney is largely determined by the activity of OCTs. 9) Metformin is a substrate of OCT1, and excessive hepatic levels of such biguanides can lead to lactic acidosis. 10) In addition, in Oct1 knockout mice, accumulation Recently, we demonstrated that a pregnane X receptor (PXR) ligand affected the pharmacokinetic properties of organic cations in vivo and in vitro by up-regulating the expression of rat Oct1 and probably also rat Oct2.
11) Moreover, we examined the effect of various ligands of nuclear receptors other than PXR on the expression level of rat Oct1 mRNA in primary-cultured rat hepatocytes, while they did not show significant effect on Oct1 expression. 11) However, as in the study we newly found that the Oct1 mRNA level was decreased by exposure to dexamethasone, a ligand of glucocorticoid receptor (GR), we examined the involvement and significance of GR in the hepatic handling of cationic drugs by means of in rats. Animals Experiments: Male Wistar rats (200-260 g bodyweights) were obtained from Saitama Experimental Animals Supply Co., Ltd. (Saitama, Japan), and were housed three per cage with free access to commercial chow and tap water, maintained on a 12-h dark/light cycle (8:00 AM-8:00 PM light) in an air-controlled room (temperature, 24.5±19 C; humidity, 55±5%). They were handled with humane care under the guidelines for the animal experimentation of the Tokyo University of Science.
Materials and Methods
Isolation and Culturing of Rat Hepatocytes: Rat hepatocytes were isolated by calcium two-step collagenase perfusion methods as described by Tamai et al. 12) Briefly, rats were anesthetized with diethyl ether prior to portal vein cannulation. The liver was perfused in situ with oxygenated EGTA buffer (8. 2 ) was cultured in 24-well plates that had been coated with type I collagen. They were cultured for 3 h after inoculation under 5% CO2 at 379 C. The medium was then replaced with fresh DMEM containing 70 mg/L streptomycin, 139 mg/L penicillin, 2 g/L BSA, and the cells were cultured for 24 h under 5% CO2 at 379 C.
Cell Culture and Ligand Treatment: Rat hepatoma RL-34 cells (JCRB cell bank, Osaka, Japan) were cultured in DMEM supplemented with 10% FBS. Rat hepatocytes and RL-34 cells were seeded at the concentration of 2.5×10 5 cells/well in 6-well plates. At 24 h after cultivation, the cells were cultured in DMEM containing ligand of nuclear receptors.
Semi-Quantitative Reverse Transcription Polymerase Chain Reaction: Total RNA was prepared from the rat hepatocyte using ISOGEN (Wako Pure Chemical Industries, Tokyo, Japan). The total RNA content was determined by measuring the absorbance at 260 nm. mRNA level of rat hepatocyte was analyzed using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). Single-strand cDNAs were constructed using an oligo(dT) primer (Invitrogen) and ImProm-II TM reverse transcriptase (Promega, Madison, WI). These cDNAs provided templates for PCRs using specific primers ( Table 1) for PCR by denaturation at 949 C for 30 sec, an annealing temperature of 58-629 C for 30-60 sec, and an elongation temperature of 729 C for 30 sec in the presence of deoxynucleotides (dNTPs) and Ex Taq TM polymerase (Takara Shuzo Co. Ltd., Tokyo). Annealing time and temperature were changed as required depending on the genes. The PCR cycle numbers were titrated for each primer pair to confirm that amplification was performed within a linear range. PCR products were analyzed by 2% agarose gel (w/v) electrophoresis and the gels were stained with ethidium bromide for visualization. mRNA levels were quantified by using light capture (Atto Co., Tokyo). PCR amplification data were normalized with respect to glyceraldehyde-3-phosphate dehydrogenase (G3PDH). The quantitation of each gene was repeated at least three times using RNA sources isolated from independently cultured cells, and the results were statistically analyzed by the use of Student's t test.
Uptake Study by Primary-Cultured Rat Hepatocytes: For uptake measurement, hepatocytes were isolated from the livers of male Wistar rats. The hepatocytes suspensions (1.0× 10 5 viable cells/cm 2 ) was cultured in 24-well plates that had Time-dependent suppression of rat Oct1 mRNA by dexamethasone in primary-cultured rat hepatocytes Primary-cultured rat hepatocytes were treated with dexamethasone (100 mM). Semi-quantitative RT-PCR was performed with total RNA extracted from the primary-cultured rat hepatocytes. PCR products were electrophoresed on 2% agarose gel and stained with ethidium bromide (A). mRNA levels of rat Oct1 were normalized by the expression level of G3PDH (B H]TCA to the cells. At appropriate times, the cells were washed three times with icecold uptake buffer to terminate the uptake. To solubilize the cells, 250 mL of 1 M NaOH was added to each well and the plate was left at room temperature for 6 h. After neutralization with 50 mL of 5 M HCl, the cells were transferred to a tube and mixed with liquid scintillation cocktail (Cleasol-1, Nacalai Tesque, Kyoto, Japan), and then the radioactivity was quantified with a liquid scintillation counter (Aloka, Tokyo, Japan).
Analytical Methods: Cellular protein content was determined according to the method of Lowry et al. 13) with BSA as the standard. Usually, initial uptake rates were obtained by measuring the uptake at each time, as described in figures. Cell-to-medium ratio (mL/mg protein) was obtained by dividing the uptake amount by the cells by the concentration of test compound in the uptake medium.
All data were expressed as mean±S.E.M., and statistical analysis was performed by Student's t test. The criterion of significance was taken to be pº0.05.
Results
Effect of dexamethasone on the expression of rat Oct1: When primary cultured rat hepatocytes and RL-34 cells were exposed to dexamethasone (DEX), a ligand of glucocorticoid receptor (GR), the mRNA level of rat Oct1 was decreased to about 40% of control (Fig. 1) . Time (6-48 h) and concentration (0.1-100 mM) dependences of the effect of DEX on the suppression of the expression of rat Oct1 were examined in primary cultured rat hepatocytes. The mRNA levels of rat Oct1 was maximally decreased in 24 h (Fig. 2) and at 100 mM of DEX (Fig. 3) .
Uptake of MPP ＋ and TCA by primary cultured rat hepatocytes: To identify the transporter involved in
＋ uptake in rat hepatocytes, we examined the inhibitory effects of various compounds on the uptake of MPP ＋ by primary cultured rat hepatocytes (Fig. 4) . As inhibitors of transporters, procainamide and corticosterone were used for organic cation transporters, estrone-3-sulfate (E13S) and paminohippuric acid (PAH) were for organic anion transporters, and carnitine as zwitterionic transporters were selected. Procainamide and corticosterone inhibited the uptake of [ 3 
H]MPP
＋ by primary cultured rat hepatocytes, whereas E13S, PAH and carnitine showed negligible effect. The rank order of the inhibitory effects of MPP ＋ uptake by primary cultured rat hepatocytes was similar to that reported for MPP ＋ uptake by rat Oct1 (IC50 procainamide 20 mM and corticosterone 151 mM, respectively). 14) We further investigated the effect of DEX on the hepatic uptake of MPP ＋ by primary cultured rat hepatocytes. Initial studies determined that uptake of [ 3 H]MPP ＋ (1 mM) and [ 3 H]TCA (1 mM) by primary cultured rat hepatocytes treated for 24 h with DMSO (0.1%) or DEX (100 mM) were linearly increased for 5 min, respectively (Fig. 5 ). Uptake of [ 3 H]MPP ＋ was significantly decreased at 2, 3, and 5 min when the cells were Fig. 3 . Dose-dependent suppression of rat Oct1 mRNA by dexamethasone in primary-cultured rat hepatocytes Primary-cultured rat hepatocytes were treated with dexamethasone for 24 h before harvest and semi-quantitative RT-PCR was performed with total RNA extracted from the cells. PCR products were electrophoresed on 2% agarose gel and stained with ethidium bromide (A). mRNA levels of rat Oct1 were normalized by the expression level of G3PDH (B). Each point represents the mean± S.E.M. from three to seven experiments. ( * ) indicates a significant difference from the control by Student t-test (pº0.05). (1 mM) at 3 min in primary cultured rat hepatocytes were measured. The inhibitor used were procainamide (10, 100, and 1000 mM), corticosteron (10, 100, and 500 mM), carnitine (100 mM), E 1 3S (100 mM), and PAH (500 mM). Each point represents the mean± S.E.M. from three or four experiments. (*) indicates a significant difference from the control (Student's t-test; pº0.05). 
70
Tomoji MAEDA, et al.
treated with DEX, while uptake of [ 3 H]TCA, which is a substrate of sodium-dependent bile acid transporter in liver (Ntcp), 15) was not changed. Moreover, uptake of MPP ＋ by primary cultured rat hepatocytes represented a single saturable component by Eadie-Hofstee plot analysis (Fig. 6) . The Km and Vmax values of MPP ＋ uptake by primary cultured rat hepatocytes treated for 24 h with DMSO (0.1%) or DEX (100 mM) were 5.99 mM and 48.1 pmol/3 min/mg, and 6.18 mM and 26.4 pmol/3 min/mg, respectively.
Effect of GR antagonist on the expression of rat Oct1:
Since DEX is a ligand of GR, the involvement of GR in the expression of rat Oct1 was further examined by RU486, an antagonist of GR (Fig. 7) . When DEX and RU486 were exposed to primary cultured rat hepatocytes together, rat Oct1 expression level was not changed. This result suggests that GR is involved in the regulation of the expression of rat Oct1. Although RU486 is a potent antagonist of GR, this compound is an agonist for the PXR. So, dose-dependence of DEX on the expression of PXR mRNA was examined in primary cultured rat hepatocytes at the concentrations from 0.1 to 100 mM (Fig. Fig. 7 . Effect of RU486 on the expression of rat Oct1 in primary cultured rat hepatocytes exposed to dexamethasone Primary cultured rat hepatocytes were treated for 24 h with 0.1% DMSO, 100 mM dexamethasone alone, 10 mM RU486 alone, and both 10 mM RU486 and 100 mM dexamethasone. Semi-quantitative RT-PCR was performed with total RNA extracted from those cells. rat Oct1 mRNA level was analyzed by RT-PCR. PCR products were electrophoresed on 2% agarose gel and stained with ethidium bromide (A). mRNA levels of rat Oct1 were normalized by the expression level of G3PDH (B). Each point represents the mean± S.E.M. from three to seven experiments. (*) indicates a significant difference from the control by Student t-test (pº0.05). 
8).
The mRNA level of PXR was decreased at concentrations higher than 10 mM of DEX. So, the change of expression level of rat Oct1 by DEX might be also explainable by the change of PXR expression level.
Discussion
In the present study, the factor that affects the apparent activity of organic cation transporter Oct1 in rat liver was examined by focusing on the ligand-dependent nuclear receptors which may regulate the expression level of rat Oct1, since our previous study showed a decrease of the expression of rat Oct1 in the primary cultured rat hepatocytes by exposure to dexamethasone (DEX), a ligand of GR.
We initially treated the primary cultured rat hepatocytes and rat liver-derived cell line RL-34 with a GR ligand, DEX, and found that the treatment exhibited a significant decrease of rat Oct1 gene expression (Fig. 1) . Therefore, we examined whether the effect of DEX on the expression of rat Oct1 is mediated by GR or not using GR antagonist RU486 (Fig. 7) . The involvement of GR was suggested by the observation that the decrease of rat Oct1 mRNA level by DEX treatment was suppressed by RU486 treatment. Therefore, in the present study, DEX seems to work as a ligand of GR and regulated the expression of rat Oct1 via GR, resulting in the decrease of rat Oct1 expression.
To examine whether the expression of rat Oct1 was regulated directly or indirectly by GR, the presence of conserved regions of the GR binding site (GRE), was investigated in the promoter region of rat Oct1. 16 ) However, we found no sequence corresponding to GRE in the rat Oct1 promoter region up to -10 kb. It remains possible that the GRE might be located beyond the promoter region examined in the present study, and/or the promoter may contain previously unknown GRE.
Although we could not establish a direct regulation of the expression of rat Oct1 by DEX via GR, it was clearly demonstrated that the GR ligand DEX down-regulated the expression of rat Oct1 in rats. So, we then investigated the effect of changes in expression level on the rat Oct1-mediated transport activity of rat Oct1 substrates. The uptake of [ 3 H]MPP ＋ by primary cultured rat hepatocytes treated with DEX during cultivation were significantly decreased in comparison with the uptake by DMSO-treated control, while such an increase was not observed in the case of [ 3 H]TCA uptake. So, the decreased uptake activity can be explained in terms of decreased expression level of rat Oct1 in vitro (Fig. 5) . Although the Km values for primary cultured rat hepatocytes treated with DEX was similar to that of control, Vmax values for primary cultured rat hepatocytes treated with DEX was smaller than that of control. Therefore, it was suggested that a decrease of rat Oct1 expression by DEX is relevant to the decrease of organic cation transport activity in rat hepatocytes.
Previously, we evaluated the effect of a PXR ligand of pregnenolone-16alpha-carbonitrile (PCN) on the expression of rat Oct1.
11) As a result, the mRNA level of rat Oct1 was up-regulated by PCN by both the in vivo and in vitro experiments. In addition, isolated rat hepatocytes exhibited an increase of MPP ＋ uptake by the treatment with PCN. When rats were subcutaneously administered with PCN, an increase of biliary excretion clearance and distribution volume was observed for drugs such as MPP ＋ , metformin, and tetraethylammonium, although the effects on phamacokinetic parameters were variable among the tested drugs. In the present study, since a high concentration of DEX (À10 mM) decreased the expression of PXR (Fig. 8) , it is also possible that a decrease of rat Oct1 expression by DEX is due to the decrease of the expression of PXR. Therefore, it is possible that DEX could alter the pharmacokinetic parameters of organic cations by the two mechanisms, including GR-mediated direct regulation or PXR-mediated indirect regulation of the expression of rat Oct1.
GR associates with the expressional regulation of many metabolic enzymes and transporters such as CYP7A1, multidrug resistance-associated protein 2 and multidrug resistance protein 1a/b. [17] [18] [19] In addition, antifungal azole-derived drugs such as ketoconazole and miconazole are antagonists of the GR. 20) Therefore, since it is possible that certain drugs are GR ligands, alterations of hepatic handling of drugs may be caused by the interactions between cationic drugs that are substrates of rat Oct1 and ligands of GR. Accordingly, the regulatory mechanisms of drug transporters by nuclear receptors should have a significant influence on the pharmacokinetic properties and consequently on the efficacy and/or toxicity of drugs.
